期刊
BIOSENSORS & BIOELECTRONICS
卷 49, 期 -, 页码 231-235出版社
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2013.05.028
关键词
Alzheimer's disease; beta-Amyloid; Heme; Gold nanoparticles; Electrocatalysis; O-2 reduction
类别
资金
- National Natural Science Foundation of China [21205003]
- China Scholarship Council [2009637056]
- Science & Technology Foundation of Henan Province [122102310517]
beta-Amyloid (A beta) peptides are believed to be important for the diagnosis and prognosis of Alzheimer's disease (AD) serving as reliable molecular biomarkers. In this work, we reported a simple and sensitive electrochemical strategy for the detection of total A beta peptides using gold nanoparticles modified with A beta (1-16)-heme (denoted as A beta(1-16)-heme-AuNPs). Monoclonal antibody (mAb) specific to the common N-terminus of A beta was immobilized onto gold electrode for the capture of A beta(1-16)-heme-AuNPs. The anchored A beta(1-16)-heme-AuNPs showed strong electrocatalytic O-2 reduction. Pre-incubation of the mAb-covered electrode with native A beta decreased the amount of A beta(1-16)-heme-AuNPs immobilized onto the electrode, resulting in the decrease of the reduction current of O-2 to H2O2. The competitive assay is sensitive and selective to A beta peptides. The voltammetric responses were found to be proportional to the concentrations of A beta ranging from 0.02 to 1.50 nM, and a detection limit of 10 pM was achieved. To demonstrate the viability of the method for the analysis of A beta in real sample, artificial cerebrospinal fluid (aCSF) containing A beta(1-40), A beta(1-42) and A beta(1-16) was tested. We believe that the method would offer a useful means for quantifying A beta in a biological matrix, and be valuable in the design of new types of electrochemical biosensors for the detection of peptides and proteins. (C) 2013 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据